AbbVie (ABBV) Exchange Rate Effect (2013 - 2026)

AbbVie (ABBV) has 14 years of Exchange Rate Effect data on file, last reported at -$12.0 million in Q1 2026.

• Exchange Rate Effect for Q1 2026 came in at -$12.0 million, down 233.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.0 million (up 155.26% YoY), and the FY2025 annual result was $42.0 million, up 164.62% from the prior year.
• Exchange Rate Effect retreated to -$12.0 million in Q1 2026 per ABBV's latest filing, from $11.0 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $30.0 million in Q2 2025 and troughed at -$59.0 million in Q3 2022.
• A 5-year average of -$5.4 million and a median of -$8.0 million in 2025 frame the typical range for Exchange Rate Effect.
• The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect slumped 325.0% in 2024, then surged 433.33% in 2025.
• A 5-year view of Exchange Rate Effect shows it stood at $23.0 million in 2022, then changed by 0.0% to $23.0 million in 2023, then sank by 300.0% to -$46.0 million in 2024, then jumped by 123.91% to $11.0 million in 2025, then plunged by 209.09% to -$12.0 million in 2026.
• Business Quant data shows ABBV's Exchange Rate Effect at -$12.0 million in Q1 2026, $11.0 million in Q4 2025, and -$8.0 million in Q3 2025.